REDUCE: Does Antipsychotic Dose Reduction Lead to Better Functional Recovery in First Episode Psychosis: A Randomised Controlled Trial

This dataset pertains to a randomized controlled trial investigating whether reduced antipsychotic dosage combined with Evidence-Based Intensive Recovery Treatment (EBIRT) leads to improved functioning in young people recovering from first episode psychosis (FEP). The trial includes two groups: one receiving a dose reduction strategy (DRS+) combined with EBIRT, and the other receiving antipsychotic maintenance treatment (AMTx+) along with EBIRT. Additionally, 40 healthy controls will be assessed for comparison across multiple time points. The study aims to assess clinical, cognitive, and physical health outcomes over a 15-18 month treatment period with follow-up at 24 months.